Literature DB >> 28514695

New product trial, use of edibles, and unexpected highs among marijuana and hashish users in Colorado.

Jane A Allen1, Kevin C Davis2, Jennifer C Duke2, James M Nonnemaker2, Brian R Bradfield2, Matthew C Farrelly2.   

Abstract

OBJECTIVE: This study examines the relationships between trial of new marijuana or hashish products and unexpected highs, and use of edible products and unexpected highs.
METHODS: We conducted an online survey of 634 adult, past-year marijuana users in Colorado. We used logistic regression models to examine the relationship between new product trial or edible use and unexpected highs.
RESULTS: In the first year that recreational marijuana was legal in Colorado, 71.4% of respondents tried a new marijuana or hashish product, and 53.6% used an edible product. Trial of new products was associated with greater odds of experiencing an unexpected high after controlling for age, gender, education, mental health status, current marijuana or hashish use, and mean amount of marijuana or hashish consumed in the past month (OR=2.13, p<0.001). Individuals who reported having used edibles had greater odds of experiencing an unexpected high, after controlling for the same set of variables (OR=1.56, p<0.05).
CONCLUSION: People who try new marijuana or hashish products, or use edible marijuana or hashish products, are at greater risk for an unexpected high. It is possible that some negative outcomes associated with marijuana use and unexpected highs may be averted through a better understanding of how to use product packaging to communicate with consumers.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Communication; Edible; Hashish; Marijuana; Packaging; Policy

Mesh:

Substances:

Year:  2017        PMID: 28514695     DOI: 10.1016/j.drugalcdep.2017.03.006

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  7 in total

1.  Regulating Cannabis Manufacturing: Applying Public Health Best Practices from Tobacco Control.

Authors:  Daniel G Orenstein; Stanton A Glantz
Journal:  J Psychoactive Drugs       Date:  2018-02-13

Review 2.  Interpol review of controlled substances 2016-2019.

Authors:  Nicole S Jones; Jeffrey H Comparin
Journal:  Forensic Sci Int Synerg       Date:  2020-05-24

3.  Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study.

Authors:  Andrew A Monte; Shelby K Shelton; Eleanor Mills; Jessica Saben; Andrew Hopkinson; Brandon Sonn; Michael Devivo; Tae Chang; Jacob Fox; Cody Brevik; Kayla Williamson; Diana Abbott
Journal:  Ann Intern Med       Date:  2019-03-26       Impact factor: 25.391

4.  Copycat and lookalike edible cannabis product packaging in the United States.

Authors:  Danielle C Ompad; Kyle M Snyder; Simon Sandh; Daniel Hagen; Kewanda J Collier; Emily Goldmann; Melody S Goodman; Andy S L Tan
Journal:  Drug Alcohol Depend       Date:  2022-03-15       Impact factor: 4.852

5.  How and why adults use cannabis during physical activity.

Authors:  Whitney L Ogle; Gregg J Gold; Lukas E Coppen; Claire Copriviza
Journal:  J Cannabis Res       Date:  2022-05-18

6.  Evaluation of reinforcing and aversive effects of voluntary Δ9-tetrahydrocannabinol ingestion in rats.

Authors:  Daniel G Barrus; Timothy W Lefever; Jenny L Wiley
Journal:  Neuropharmacology       Date:  2018-05-03       Impact factor: 5.250

Review 7.  Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health.

Authors:  Justin Matheson; Bernard Le Foll
Journal:  Front Psychiatry       Date:  2020-09-23       Impact factor: 4.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.